Korean J Obstet Gynecol.
2007 Feb;50(2):314-321.
Gonadotropin-releasing hormone agonist treatments reduce aromatase and cyclooxygenase-2 in ovarian endometrioma and eutopic endometium in women with endometriosis
- Affiliations
-
- 1Department of Obstetrics and Gynecology, Ilsan Paik Hospital, Inje University, Ilsan, Korea.
- 2Clinical Research Centers, Ilsan Paik Hospital, Inje University, Ilsan, Korea.
- 3Department of Obstetrics and Gynecology, Ajou University School of Medicine, Korea. kjhwang@ajou.ac.kr
- 4Department of Molecular Science and Technology, Graduate School of Medicine, Ajou University, Suwon, Korea.
Abstract
OBJECTIVE
We investigated whether GnRH agonists reduce aromatase cytochrome P450 and cyclooxygenase-2 by direct action in the eutopic endometrium of endometriosis and ovarian endometrioma.
METHODS
Endometrial specimens and endometriotic tissues were obtained from infertility women undergoing laparoscopic surgery. Biopsy samples of the endometrium were obtained before and after GnRH agonist therapy. The stromal cells of eutopic endometrium in women with endometroisis and ovarian endometrioma were cultured in the presence of GnRH agonist (leuprolide acetate 0, 1, 5, and 10 uM) for 24 hours. The expression of aromatase cytochrome P450 and COX-2 was examined by Western blot.
RESULTS
Protein of aromatase cytochrome P450 and COX-2 were decreased in the eutopic endometrium of patients treated with GnRH agonist for 3 months. The stromal cells culture of endometrial explants and ovarian endometrioma with GnRH agonist reduced aromatase cytochrome P450 and COX-2. Phosphorylated ERK was decreased in endometriotic stromal cultures with GnRH agonist.
CONCLUSION
These findings demonstrate that GnRH agonist not only promoted a hypoestrogenic state but also reduced aromatase cytochrome P450 and COX-2 by direct action on eutopic endometrium in patients with endometriosis and ovarian endometrioma.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A study of low dose purified follicle-stimulating hormone supplemented with gonadotropin releasing hormone agonist in women with polycystic ovarian disease
- Therapy for idiopathic precocious puberty in children
- Ovulation induction with combined gonadotropin-releasing hormone agonist(K-Trp-Luteinizing houmone-Releasing hormone:decapeptyl) and gonadotropins in women with polycystic ovarian disease
- The effective of ultrashort-term gonadotropin-releasing hormone agonist administration in controlled ovarian hyperstimulation for in vitro fertilization
- Three Cases of Parenchymal Pulmonary Endometriosis
